Abstract
Specific absorbed fractions (PHI's) in various organs of the body (target organs) from sources of monoenergetic photons in various other organs (source organs) are tabulated. This volume outlines various methods used to compute the PHI-values and describes how the ''best'' estimates recommended by us are chosen. These PHI-values can be used in calculating the photon component of the dose-equivalent rate in a given target organ from a given radionuclide that is present in a given source organ. The International Commission on Radiological Protection recognizes that the endosteal, or bone surface, cells are the tissue at risk for bone cancer. We have applied the dosimetry methods that Spiers and co-workers developed for beta-emitting radionuclides deposited in bone to follow the transport of secondary electrons that were freed by photon interactions through the microscopic structure of the skeleton. With these methods we can estimate PHI in the endosteal cells and can better estimate PHI in the active marrow; the latter is overestimated with the methods at photon energies below 200 keV. 41 refs., 25 figs., 23 tabs.

This publication has 0 references indexed in Scilit: